Export

Eurofins Biopharma Product Testing Sweden AB

Financial information

The information source is the annual report of the company with business id 556225-2196

* Closing information (×1000) SEK

Fiscal year 202412 202312
Number of months: 12 12
Turnover: 87,739 Revenue Up 67,508 Revenue Up
Financial expenses: 1,883 Revenue Down 2,592 Revenue Up
Earnings before taxes: -9,918 Revenue Up -20,374 Revenue Up
Total assets: 26,500 Revenue Down 36,643 Revenue Down
Current assets: 19,744 Revenue Down 21,057 Revenue Down
Current liabilities: 16,453 Revenue Down 21,816 Revenue Up
Equity capital: -6,985 Revenue Up -18,668 Revenue Down
Share capital: 100 100
Number of employees: 38 Revenue Down 46 Revenue Down

Financial ratios

Solvency: -26.4% Revenue Up -50.9% Revenue Down
Turnover per employee: 2,309 Revenue Up 1,468 Revenue Up
Profitability: -11.3% Revenue Up -30.2% Revenue Up
Return on equity (ROE): 142.0% Revenue Up 109.1% Revenue Up
Current ratio: 120.0% Revenue Up 96.5% Revenue Down
Return on assets (ROA): -30.3% Revenue Up -48.5% Revenue Down

Companies with similar products and services, and with detailed information

Fiscal year 202412
Number of months: 12
Turnover: 87,739
Financial expenses: 1,883
Earnings before taxes: -9,918
Total assets: 26,500
Current assets: 19,744
Current liabilities: 16,453
Equity capital: -6,985
Share capital: 100
Number of employees: 38

Financial ratios

Solvency: -26.4%
Turnover per employee: 2,309
Profitability: -11.3%
Return on equity (ROE): 142.0%
Current ratio: 120.0%
Return on assets (ROA): -30.3%